ENvue Medical interim CFO files Form 3

ENvue Medical, Inc. reported that Nicole M. Fernandez-McGovern, the company’s Interim CFO, filed an initial statement of beneficial ownership on Form 3.

Rhea-AI Filing Summary

ENvue Medical, Inc. reported that Nicole M. Fernandez-McGovern, the company’s Interim CFO, filed an initial statement of beneficial ownership on Form 3. This filing establishes her official insider status and discloses her equity position in the company as required for officers under SEC rules.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ENvue Medical (FEED) Form 3 filing for Nicole M. Fernandez-McGovern mean?

The Form 3 filing shows that Interim CFO Nicole M. Fernandez-McGovern is now a registered insider of ENvue Medical. It records her initial beneficial ownership position as an officer, satisfying SEC disclosure rules for transparency around management’s equity interests.

Who is the insider named in ENvue Medical (FEED) latest Form 3 filing?

The insider is Nicole M. Fernandez-McGovern, who serves as Interim CFO of ENvue Medical. As an executive officer, she must report her beneficial ownership in company securities, and Form 3 is the initial statement that establishes her reporting obligations.

Does the ENvue Medical (FEED) Form 3 filing show any stock transactions?

The Form 3 data provided lists no reported transactions, focusing instead on insider status and initial ownership. Form 3 is typically used to declare existing holdings when someone first becomes an officer, director, or large shareholder subject to SEC reporting rules.

Why is Nicole M. Fernandez-McGovern’s Form 3 important for ENvue Medical (FEED) investors?

The Form 3 is important because it confirms Interim CFO Nicole M. Fernandez-McGovern as a reporting insider and documents her equity stake. This transparency helps investors understand management’s alignment with shareholders through beneficial ownership in ENvue Medical securities.

How does a Form 3 differ from Form 4 for ENvue Medical (FEED) insiders?

Form 3 is the initial statement of beneficial ownership filed when someone becomes an insider at ENvue Medical. Form 4, by contrast, reports subsequent changes in that ownership, such as purchases, sales, or awards, after the initial position has been disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 07:46 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Fernandez-McGovern Nicole M.

(Last) (First) (Middle)

969 PRUITT AVE.

(Street)

TYLER TX 77569

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
ENvue Medical, Inc. [ FEED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Nicole M. Fernandez-McGovern	02/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.